Browse Catapults

News from the catapult network

News headlines from across the Catapult Network. For comprehensive news updates, please explore our Politics Home webpage or visit individual Catapult websites

Medicines Discovery
Graphic for Medicines Discovery Catapult's annual report
News
Medicines Discovery Catapult Annual Report Published, For the Year Ended 31 March 2024
Medicines Discovery Catapult Limited’s Annual Report for the year ended 31 March 2024 is now published. The Financial Year 2023/24 was highly challenging for international biotech. It saw a 50% decline in venture capital funding, driven by global economic forces and also – in the UK – a rise in operating costs, driven by inflation and the scarcity of key resources in skills and space. This Annual Report shows that despite this challenging economic background, Medicines Discovery Catapult’s overall contribution to medicines discovery in the UK continues to grow.
Read more
Cell and Gene Therapy
News
Patient first: Highlights from the RSM’s “Unveiling Gene Therapy: Transforming medical practice through ATMPs” event
The field of gene therapy is witnessing unprecedented advancements, marked by innovative treatments and expanding possibilities. As we navigate this dynamic landscape, it is crucial to centre our efforts around the very individuals these therapies aim to benefit—the patients. We recently attended the Royal Society of Medicine’s (RSM) “Unveiling Gene Therapy: Transforming medical practice through ATMPs” event. In this blog, Dan Gibson, Head of Collaborations at the Cell and Gene Therapy Catapult, reflects on his thoughts following the meeting, exploring how patient-centric approaches are not just a moral imperative but a scientific necessity for the future of gene therapy.
Read more